These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 15448164)
1. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. Chang TS; Jeong W; Woo HA; Lee SM; Park S; Rhee SG J Biol Chem; 2004 Dec; 279(49):50994-1001. PubMed ID: 15448164 [TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of the reduction of cysteine sulfinic acid of peroxiredoxin to cysteine by mammalian sulfiredoxin. Jeong W; Park SJ; Chang TS; Lee DY; Rhee SG J Biol Chem; 2006 May; 281(20):14400-7. PubMed ID: 16565085 [TBL] [Abstract][Full Text] [Related]
3. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. Woo HA; Jeong W; Chang TS; Park KJ; Park SJ; Yang JS; Rhee SG J Biol Chem; 2005 Feb; 280(5):3125-8. PubMed ID: 15590625 [TBL] [Abstract][Full Text] [Related]
4. Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance. Rhee SG; Jeong W; Chang TS; Woo HA Kidney Int Suppl; 2007 Aug; (106):S3-8. PubMed ID: 17653208 [TBL] [Abstract][Full Text] [Related]
5. Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin. Jönsson TJ; Tsang AW; Lowther WT; Furdui CM J Biol Chem; 2008 Aug; 283(34):22890-4. PubMed ID: 18593714 [TBL] [Abstract][Full Text] [Related]
6. Sulfiredoxin Translocation into Mitochondria Plays a Crucial Role in Reducing Hyperoxidized Peroxiredoxin III. Noh YH; Baek JY; Jeong W; Rhee SG; Chang TS J Biol Chem; 2009 Mar; 284(13):8470-7. PubMed ID: 19176523 [TBL] [Abstract][Full Text] [Related]
7. Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate. Jönsson TJ; Murray MS; Johnson LC; Lowther WT J Biol Chem; 2008 Aug; 283(35):23846-51. PubMed ID: 18579529 [TBL] [Abstract][Full Text] [Related]
8. Reduction of cysteine sulfinic acid in eukaryotic, typical 2-Cys peroxiredoxins by sulfiredoxin. Lowther WT; Haynes AC Antioxid Redox Signal; 2011 Jul; 15(1):99-109. PubMed ID: 20712415 [TBL] [Abstract][Full Text] [Related]
9. The Arabidopsis thaliana sulfiredoxin is a plastidic cysteine-sulfinic acid reductase involved in the photooxidative stress response. Rey P; Bécuwe N; Barrault MB; Rumeau D; Havaux M; Biteau B; Toledano MB Plant J; 2007 Feb; 49(3):505-14. PubMed ID: 17217469 [TBL] [Abstract][Full Text] [Related]
10. Concerted action of sulfiredoxin and peroxiredoxin I protects against alcohol-induced oxidative injury in mouse liver. Bae SH; Sung SH; Cho EJ; Lee SK; Lee HE; Woo HA; Yu DY; Kil IS; Rhee SG Hepatology; 2011 Mar; 53(3):945-53. PubMed ID: 21319188 [TBL] [Abstract][Full Text] [Related]
11. Deglutathionylation of 2-Cys peroxiredoxin is specifically catalyzed by sulfiredoxin. Park JW; Mieyal JJ; Rhee SG; Chock PB J Biol Chem; 2009 Aug; 284(35):23364-74. PubMed ID: 19561357 [TBL] [Abstract][Full Text] [Related]
12. Evolution of eukaryotic cysteine sulfinic acid reductase, sulfiredoxin (Srx), from bacterial chromosome partitioning protein ParB. Basu MK; Koonin EV Cell Cycle; 2005 Jul; 4(7):947-52. PubMed ID: 15917647 [TBL] [Abstract][Full Text] [Related]
13. Sestrin 2 is not a reductase for cysteine sulfinic acid of peroxiredoxins. Woo HA; Bae SH; Park S; Rhee SG Antioxid Redox Signal; 2009 Apr; 11(4):739-45. PubMed ID: 19113821 [TBL] [Abstract][Full Text] [Related]
14. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Biteau B; Labarre J; Toledano MB Nature; 2003 Oct; 425(6961):980-4. PubMed ID: 14586471 [TBL] [Abstract][Full Text] [Related]
15. Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression. Jeong W; Bae SH; Toledano MB; Rhee SG Free Radic Biol Med; 2012 Aug; 53(3):447-56. PubMed ID: 22634055 [TBL] [Abstract][Full Text] [Related]
16. Structural basis for the retroreduction of inactivated peroxiredoxins by human sulfiredoxin. Jönsson TJ; Murray MS; Johnson LC; Poole LB; Lowther WT Biochemistry; 2005 Jun; 44(24):8634-42. PubMed ID: 15952770 [TBL] [Abstract][Full Text] [Related]
17. Mutagenesis and modeling of the peroxiredoxin (Prx) complex with the NMR structure of ATP-bound human sulfiredoxin implicate aspartate 187 of Prx I as the catalytic residue in ATP hydrolysis. Lee DY; Park SJ; Jeong W; Sung HJ; Oho T; Wu X; Rhee SG; Gruschus JM Biochemistry; 2006 Dec; 45(51):15301-9. PubMed ID: 17176052 [TBL] [Abstract][Full Text] [Related]
18. Irreversible oxidation of the active-site cysteine of peroxiredoxin to cysteine sulfonic acid for enhanced molecular chaperone activity. Lim JC; Choi HI; Park YS; Nam HW; Woo HA; Kwon KS; Kim YS; Rhee SG; Kim K; Chae HZ J Biol Chem; 2008 Oct; 283(43):28873-80. PubMed ID: 18725414 [TBL] [Abstract][Full Text] [Related]
19. Protein engineering of the quaternary sulfiredoxin.peroxiredoxin enzyme.substrate complex reveals the molecular basis for cysteine sulfinic acid phosphorylation. Jönsson TJ; Johnson LC; Lowther WT J Biol Chem; 2009 Nov; 284(48):33305-10. PubMed ID: 19812042 [TBL] [Abstract][Full Text] [Related]
20. Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. Yang KS; Kang SW; Woo HA; Hwang SC; Chae HZ; Kim K; Rhee SG J Biol Chem; 2002 Oct; 277(41):38029-36. PubMed ID: 12161445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]